Carlo Besta Neurological Institute   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Milan Italy (1918)

Organization Overview

First Clinical Trial
2006
NCT00397072
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Carlo Besta Institute, Milan, Italy | Carlo Besta Neurological Institute | Carlo Besta Neurologic Institute | Istituto Nazionale Neurologico Carlo Besta

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Burning Mouth Syndrome (Phase 2)

Burns (Phase 2)

Glioblastoma (Phase 2)

Muscle Weakness (Phase 3)

Muscular Atrophy (Phase 2)

Muscular Atrophy, Spinal (Phase 2)

Myasthenia Gravis (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 5